Validation gaps in Medicine

Representative open questions

Showing 30 of 663 — one per source paper, highest-quality first.

• From parasite-induced immune activation to neuroinflammation and behavioral dysfunction: convergent mechanisms across protozoa and helminths: a review (2026) · doi

  Integrated multi-pathogen control strategies addressing polyparasitism are proposed but lack empirical validation against single-species interventions. Randomized controlled trials comparing deworming plus nutritional supplementation efficacy across polypara­sitic populations versus moninfected cohorts are needed to quantify the cumulative pathogenic burden reduction on the gut–brain axis.

• Heart-brain axis pathophysiological understanding and clinical impact (2026) · doi

  High-sensitivity cardiac troponin T elevation in acute ischemic stroke patients (references 109, 114, 118) lacks standardized predictive thresholds and timing protocols; prospective studies defining optimal troponin measurement intervals and cutoff values for identifying neurogenic cardiac injury are needed.

• Multifunctional Lipid Polymer Hybrid Nanocarriers in Cancer Therapy: Recent Developments and Challenges (2026) · doi

  FST-loaded LPHNPs (F3) demonstrated sustained release for up to 48 hours in phosphate buffer at pH 7.4, but the formulation has only been evaluated in acute pancreatitis models in rats; clinical translation and efficacy validation in human pancreatic tissue or comparative studies with existing pancreatitis therapeutics are absent.

• The impact of traumatic injury on the respiratory system; a narrative review of injury-associated and clinically-induced mechanisms of trauma-associated pneumonia (2026) · doi

  Machine learning approaches have been applied to predict pneumonia in flail chest patients, but external validation of these predictive models across different trauma populations and prospective testing in clinical practice settings is lacking, limiting their generalizability and clinical utility.

• FDG-PET/CT based small volume accelerated immuno chemoradiotherapy in locally advanced NSCLC (PACCELIO) – a randomized, open-label, multicenter phase II trial protocol (2026) · doi

  The synergistic effects of combining hypofractionated, accelerated dose delivery with target volume reduction in locally advanced NSCLC have not been directly quantified in randomized trials. The biologically effective dose calculations and their relationship to both acute/late toxicity reduction and immunotherapy advancement rates require prospective validation with organ-at-risk dose constraints.

• From organelles to therapy: rethinking combined hepatocellular-cholangiocarcinoma (2026) · doi

  Organelle phenotypes must be systematically integrated with clinical features and patient outcomes in cHCC-CCA cohorts to establish whether organelle biology can predict treatment response and prognosis, enabling precision medicine approaches that match organelle-targeting agents to individual tumor biology.

• Can deep learning-based segmentation and classification improve the detection of renal cortical abnormalities? (2026) · doi

  While the study developed a 693-patient dataset to improve generalizability over prior datasets with fewer than 300 images, there is no external validation on independent DMSA datasets from different imaging centers or patient populations. The proposed DenseNet205 classification and DenseNet121_Self-ONN_FPN segmentation models require testing on external renal cortical abnormality datasets to establish generalization beyond the single-center cohort.

• Managing Spinal Muscular Atrophy: A Look at the Biology and Treatment Strategies (2025) · doi

  SMN2 copy number and variants have been shown to modify SMA phenotype, but the genotype-phenotype correlations in patients with complex SMN2 structural variations and deletion junctions require larger cohort validation beyond existing studies to establish predictive biomarkers for disease progression.

• Neurosurgery as an immune anchor point: a translational framework for perioperative immunoengineering (2026) · doi

  The paper identifies meningeal immunity and neuroinflammation-associated neurotoxicity from immune checkpoint inhibitor therapy but does not specify mechanistic predictors for identifying patients at high risk of severe neurological adverse events. Biomarker profiling of clonally expanded effector CD4+ cytotoxic T lymphocytes and their correlation with perioperative autonomic nervous system imbalance requires prospective validation in neurosurgical cohorts.

• The neuro-immune axis in preeclampsia: from the maternal-fetal interface to systemic dysregulation (2026) · doi

  The paper identifies that different preeclampsia subtypes (acute neurovascular instability versus placental angiogenic dysfunction) should exhibit distinct autonomic imbalance signatures, but does not specify which standardized autonomic biomarkers should be measured (heart rate variability indices, baroreceptor sensitivity, sympathetic/parasympathetic tone ratios) or establish cutoff thresholds for distinguishing PE subtypes.

• The use of artificial intelligence based modelling techniques in One Health-related infectious disease studies in Sub-Saharan Africa: a review (2026) · doi

  AI-based One Health infectious disease models in Sub-Saharan Africa currently lack systematic validation using external datasets from independent geographic regions within SSA; cross-validation and sensitivity analyses across West and Central African contexts remain largely absent from the literature.

• Gastroretentive Floating Microspheres: A Promising Approach for Site-Specific and Controlled Drug Delivery. (2026) · doi

  Section 10.2 asserts that floating microspheres are particularly effective for drugs acting locally in the stomach (gastritis, gastric ulcers, acid-related diseases) by maintaining prolonged gastric retention, but does not provide comparative efficacy data or head-to-head clinical trials comparing floating microsphere formulations to existing gastroretentive therapies (e.g., sucralfate suspension, bismuth compounds) in these disease states.

• Autologous Platelet Concentrates in Sports Medicine: Mechanisms of Tissue Regeneration and Clinical Applications – A Narrative Review (2026) · doi

  High-quality clinical trials have not adequately validated the theoretical tissue-specific matching of leukocyte-rich versus leukocyte-poor PRP formulations in tendon versus intra-articular applications, nor have they demonstrated whether PRF and i-PRF's fibrin-based scaffold properties and slower growth factor release kinetics provide superior outcomes in chronic lesions or poorly vascularized tissues.

• What is The Effect of Early Enteral Nutrition on Mortality in Critically Ill Patients Receiving Vasopressor Support? : A Systematic Review (2026) · doi

  The paper documents inconsistent mortality outcomes across disease-specific cohorts (COVID-19 pneumonia showing benefits, septic shock showing variable results, ARDS and traumatic brain injury requiring tailored approaches), yet no comparative effectiveness trials have systematically evaluated organ-dysfunction-specific feeding strategies (dose, timing, route) to determine risk-benefit profiles for ARDS, acute pancreatitis, and traumatic brain injury patients on vasopressor support.

• Decision-ready evidence for vital pulp therapy: a network meta-analysis of bioactive materials in mature permanent teeth (2026) · doi

  The network meta-analysis stratified mature permanent teeth but did not separately analyze outcomes for specific tooth types (molars vs. premolars vs. incisors) or by caries depth/location, which may differentially affect hemostasis control and restoration margins in pulpotomy procedures. Future RCTs should report subgroup analyses of absolute success rates for bioactive materials disaggregated by tooth type and caries extent.

• What is the diagnostic accuracy of different clinical diagnostic criteria (Rotterdam, NIH, and Androgen Excess Society) for identifying polycystic ovary syndrome in women of reproductive age? : A Systematic Review (2026) · doi

  Population-specific follicle count thresholds for PCOS diagnosis vary substantially across ethnic groups (Turkish women: 8 follicles, North African women: 18 follicles, Chinese adolescents: lower thresholds), yet systematic validation of Rotterdam criteria's 12-follicle threshold has not been conducted across these distinct populations to establish ethnicity-specific diagnostic criteria.

• Deep learning-based multimodal prediction of chronic kidney disease stage (2026) · doi

  The multimodal deep learning model achieves 97.9% accuracy on the current dataset, but the paper does not evaluate model performance on external validation cohorts or datasets from different clinical centers. Generalization of the CKD stage prediction model across diverse patient populations and healthcare systems with potentially different laboratory measurement standards remains unvalidated.

• Effectiveness of screening modalities for early detection of diabetic retinopathy: a systematic review and meta-analysis of tele-ophthalmology, AI-based tools, and conventional methods (2026) · doi

  Handheld fundus camera DR screening shows variable image quality and has only been evaluated in single healthcare systems; standardized protocols for handheld camera-based DR detection with quality assurance thresholds across diverse clinical settings require development.

• The Relationship between a History of Cesarean Section and The Incidence of Placenta Accreta : A Systematic Review (2026) · doi

  The Moradan et al. Iranian study found no significant differences in accreta between second versus more than two cesarean sections, contradicting most other literature. This discordance may reflect population-specific factors (surgical techniques, infection rates, tissue healing characteristics) in Iranian tertiary settings. Replication of this comparison using larger sample sizes and multicenter cohorts in both high-income and lower-income healthcare systems is needed.

• A systematic review of sample size determination in Bayesian randomized clinical trials: full Bayesian methods are rarely used (2026) · doi

  The review documents extensive use of hybrid approaches across diverse outcome types (binary, continuous, ordinal, survival, joint, count, multiple endpoints), but does not systematically compare the performance or appropriateness of hybrid versus full Bayesian sample size methods across these specific outcome data structures. Research is needed to establish when hybrid methods are justified versus when full Bayesian approaches would be superior for each outcome type.

• Antibody–drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges (2026) · doi

  The referenced work by Cai et al. (2020) characterized tissue distribution and catabolism of anti-Staphylococcus aureus THIOMAB antibody-antibiotic conjugates only in rats; translation to non-human primate models or human pharmacokinetic studies to predict clinical efficacy and safety profiles for infectious disease applications remains unaddressed.

• Unveiling the relationship of the comorbidity between depression and type 2 diabetes mellitus: a macro analysis and micro interpretation (2026) · doi

  The reciprocal intervention model for depression and T2DM comorbidity—regulating metabolic status through psychological intervention or alleviating emotional disorders through blood glucose control—requires high-quality evidence through cross-border collaborative trials. Specific clinical trial designs testing this bidirectional treatment approach across different healthcare systems remain underdeveloped.

• A behaviour and disease model of testing and isolation (2026) · doi

  The model implements idealised testing conditions with no delays in test accessibility, availability, or supply constraints. Future modelling should incorporate empirical data on test supply limitations and investigate the cascading effects on infectious prevalence when individuals cannot access tests and do not self-isolate, as well as the negative feedbacks on testing uptake for future infection episodes.

• Fast hospital discharge rates blur within-hospital ‘transmission footprint’ in bacterial genomes, as showcased with Staphylococcus aureus (2026) · doi

  The model assumes exponential generation time distributions rather than gamma distributions and does not account for hospital ward structure, variability in discharge times based on patient characteristics, or transmission pathways involving healthcare workers and visitors. These simplifications require validation by applying the phylodynamic method to empirical S. aureus genomic data combined with detailed contact tracing transmission histories.

• Engineered exosome biomedical technologies for precision diagnosis and therapy in orthopedic diseases (2026) · doi

  While circulating exosomal miRNAs (miR-21, miR-150-3p, miR-503-3p) have been identified as potential biomarkers for postmenopausal osteoporosis and osteoarthritis, their diagnostic accuracy, sensitivity, specificity, and clinical threshold values across diverse patient populations and disease stages have not been systematically validated in large prospective cohorts.

• Immune molecular mechanisms of PANoptosis in sepsis-induced acute kidney injury (2026) · doi

  The PANoptosis score has been identified as a key metric in sepsis-induced acute kidney injury, but the excerpt does not establish standardized thresholds, clinical cutoff values, or validation protocols for this scoring system across different patient populations and sepsis severities.

• Bioactive and Ion-releasing materials in minimum intervention dentistry: a clinical pathway from prevention to restorative treatment (2026) · doi

  Long-term randomised clinical trials comparing ion-releasing bioactive restorative materials (calcium, phosphate, fluoride, zinc, magnesium, silanols) are needed to test superiority in clinical outcomes such as tooth survival, secondary caries incidence, postoperative hypersensitivity, and restoration longevity using S3-level evidence-based guideline methodology.

• Treatment options for long head of biceps tendon tenodesis (2026) · doi

  The novel double 360° lasso-loop fixation technique for long head of biceps tendon tenodesis lacks long-term clinical and biomechanical studies to evaluate its reliability and durability beyond short- to mid-term follow-up periods. Specific investigations are needed comparing failure rates, cyclic displacement, and gap formation of this technique against established fixation methods over extended timeframes.

• Source-stratified gut–extraintestinal organ crosstalk in sepsis-associated acute gastrointestinal injury and paralytic ileus: the gut as both driver and target (2026) · doi

  In extraintestinal sepsis, the organ-specific pathways through which lung-, brain-, kidney-, liver-, or heart-derived insults converge on the gut to trigger secondary acute gastrointestinal injury and progression toward paralytic ileus have not been experimentally validated with source-stratified interventions targeting individual organ-to-gut axes.

• Artificial intelligence approaches to predicting treatment non-adherence in chronic diseases: a narrative review (2026) · doi

  Most adherence prediction literature terminates at machine learning model development rather than conducting prospective clinical trials to demonstrate actual impact on patient medication adherence or clinical disease control outcomes. This methodological-to-implementation gap prevents validation of whether AI-based adherence prediction models meaningfully improve treatment adherence rates in real clinical workflows.